Jeeva News
Read the latest news and explore the latest media coverage about Jeeva
July 21, 2021
New Technology to Help Increase Patient Diversity in Clinical Trials
Patient test groups for new drugs and treatments, notes Dr. Harsha Rajasimha of Jeeva Informatics, tend to be non-diverse. However, recently developed digital health technologies can help broaden participation while reducing the logistical burden on both patients and study teams.
Patient Recruitment is the Elephant Slowing the Speed of Clinical Trials
Clinical trials are the regulatory mechanisms agencies like the Food and Drug Administration (FDA) use to evaluate and review evidence of safety and efficacy of investigational medicines in humans.
With the cost of discovery and development of one novel therapy exceeding $2.5 billion over a duration of 10-15 years, according to a 2018 PhRMA report, initiating, conducting, and successfully completing a clinical trial of any kind is one of the most complex endeavors.
To read more, please download this
free white paper.
| Source: Research and Markets
World Virtual Clinical Trial Service Providers Market 2020-2025, by Type of Therapeutic Area, End-Users, Phase of Development and Key Geographies
Dublin, April 27, 2021 (GLOBE NEWSWIRE) -- The "Virtual Clinical Trial Service Providers Market by Type of Therapeutic Area, End-Users, Phase of Development (Phase I, Phase II, Phase III and Phase IV), and Key Geographies: Industry Trends and Global Forecasts, 2020-2050" report has been added to ResearchAndMarkets.com's offering.
Read full story
January 28, 2021
Jeeva Informatics Hosts Rare Disease Panel on Decentralized, Patient-Focused Clinical Trials
In recognition of Rare Disease Day 2021, Jeeva Informatics (Jeeva) brought together a panel of experts to discuss the importance of transforming the clinical trial process for rare diseases. The panel included Annie Kennedy, Chief of Policy and Advocacy, EveryLife Foundation for Rare Diseases; Thomas Lester, Former Executive Director, Audentes Therapeutics; Scott Schliebner, Senior Vice President, Scientific Affairs & Therapeutic Expertise, PRA Health Sciences; and Dr. Eric Sid, Program Director, National Center for Advancing Translational Science, Office of Rare Disease Research, (NCATS)/NIH.
Read full story
January 08, 2021
Jeeva Founder and CEO to Present to Investors at the 39th Annual JP Morgan Healthcare Conference January 11-14, 2021
Jeeva AI-driven eClinical cloud accelerates #clinicalresearch at scale with #remote #touchless #patientrecruitment and #patientretention.
Schedule an appointment with on the BIO one on one partnering portal or here: https://lnkd.in/gyQHab9
We look forward to kicking off the year with #JPM2021.
Read full story
December 21, 2020 | BioBuzz
Holiday virtual networking and celebration with friends of Jeeva hosted by Harsha Rajasimha
Read full story
December 16, 2020
Jeeva article published on Patient Worthy: Avoid These 5 Real-World Data Pitfalls When Planning your Patient Registry, Natural History, or Other Clinical Study for a Rare Disease
1. Don’t toggle between multiple software to manage the study.
2. Don’t expect your clinical team to manually configure & execute the study.
3. Don’t confuse informed consent with collecting signatures (electronic or otherwise).
4. Don’t skip planning for travel restrictions that could halt in-person office visits.
5. Don’t limit your study participants to a specific mobile device manufacturer.
November 18, 2020
Decentralizing Clinical Research for Rare Diseases at Scale with Harsha K Rajasimha
Decentralizing clinical research can have many benefits such as cutting costs. In this episode, Adam Torres and Harsha K. Rajasimha, Founder and CEO of Jeeva Informatics and Founder and Chairman of Indo US Organization for Rare Diseases, explore the benefits and process of decentralizing clinical research.
Source: MISSION MATTERS
Listen to the podcast
July 7, 2020
Podcast: Decentralizing Clinical Trials with Harsha Rajasimha from Jeeva Informatic Systems
In this interview from Rare Disease Day at the NIH, Ilana talks to Harsha Rajasimha, the CEO and founder of Jeeva Informatic Systems about how clinical trials can change to better meet rare patient needs-- in the US, India, and across the world.
Source: Wait How Do You Spell That?
Listen to the podcast
May 13, 2020
KiwiTech to Host First Online Version of its Minority Founders Demo Day
KiwiTech, a tech startup accelerator that helps early to growth-stage startups in their product development drive traction and access capital, announced that it will host the 4th edition of its Minority Founders Demo Day on May 14, 2020, virtually for the first time.
April 08, 2020
KiwiTech and Jeeva Informatics Solutions Announce Strategic Partnership
KiwiTech, LLC, an innovation platform that helps startups build viable products, drive traction, and raise capital, today announced a strategic partnership with Jeeva Informatics Solutions Inc, an AI-driven startup that builds patient-focused big data and digital health solutions for accelerating clinical research.
Source: Benzinger
Read more
March 12, 2020
Speeding Up the Search for Cures – Jeeva Informatics Solutions
By any measure, Harsha Rajasimha, PhD, was a successful man. He had published journal articles and chapters in professional textbooks; he had received patents, honors, and awards for his work. But none of these accomplishments equipped him to help his baby, who died from Edwards Syndrome, a rare congenital disease.
Source: America's SBDC
Read more
February 12, 2020
Podcast: Bringing Clinical Trials to Patients
Conducting rare disease clinical trials can be challenging because of small and geographically dispersed groups of patients who may face difficulties in travelling to trial sites. Regulatory requirements for cell and gene therapies, even if only administered once, require long-term follow ups that extend for many years and provide an ongoing burden for patients. Jeeva Informatics Solutions is seeking to address those challenges through it harnessing of digital health technologies to bring the trial to the patient. We spoke to Harsha Rajasimha, founder and CEO of Jeeva, about the challenges of conducting rare disease clinical trials, the potential of digital health technologies to address those issues, and how ready regulators and sponsors may be to embrace these technologies to transform the way they conduct clinical trials today.
Source: RARECast
Listen to the podcast
February 2020
This Startup is on a Mission to Decentralize Cell and Gene Therapy Clinical Trials
For the cell and gene therapy revolution to be fully realized, physicians, research scientists, biomanufacturing experts, advocacy groups, regulatory bodies like the Food & Drug Administration (FDA) and other key stakeholders have to “Think Different”, as Apple famously encouraged.
Source: BioBuzz
Read more
Jan. 29, 2020
Five Biotechs Poised to Advance Their Rare Disease Programs in 2020
The Biohealth Capital Region (BHCR) is at the leading edge of the rare disease market with companies like American Gene Technologies, REGENXBIO, Cerecor, Asklepion Pharmaceuticals, Lediant, and others advancing their pipelines towards rare disease treatments and cures. The region’s robust rare disease sector also includes a host of companies that support rare disease research and development like Jeeva Informatics, GeneDx, Aperiomics and HemoShear among others. In short, the portfolio of rare disease companies and growing support ecosystems make the BHCR a global hub for rare disease R&D.
Source: Steve Surdez, StoryCore contribution to BioBuzz.io
Read more
Jan. 08, 2020
CIT GAP Funds Invests in Jeeva to Decentralize and Improve Clinical Trial Operations
The Center for Innovative Technology (CIT) today announced that CIT GAP Funds has invested in Herndon, Va.-based Jeeva Informatics Solutions Inc. (Jeeva), a precision medicine data science company focused on significantly accelerating clinical trial operations by taking trials to patients’ homes. Using AI and digital health technologies, Jeeva fast tracks patient recruitment, improves adherence to trial protocols, and reduces patient burden and dropout rates, solving some of the pressing challenges in bringing innovative medicines to market effectively. Jeeva plans to use the GAP Funds investment to advance customer pilot projects and use cases for further validation.
Source: Press release
Read more
April 30, 2019
Industry Leaders Outline Five Important Elements Impacting Rare Disease Drug Development
Leaders from AstraZeneca, American Gene Technologies, REGENXBIO, GeneDX, and Jeeva Informatics Solutions recently converged on the newly redesigned 704 Quince Orchard innovation space in Gaithersburg, Maryland for a panel discussion on drug development and rare disease.
Source: BioBuzz
Read more
September 12, 2018
Summer Internship Program in Precision Medicine Creates a Win-Win for Students and Local Company
Technologies such as cloud, bigdata, nosql databases, mobile apps, wearable sensors, and healthcare data interoperability are buzz words to many, but they are technologies that are propelling the healthcare-IT field forward into new frontiers. The possibilities these technologies bring can aide in patient engagement, data aggregation, integration and analytics for precision medicine. This is the cutting-edge space that Jeeva Informatics, a local company, operates in. It’s also a very attractive field for students who are eager to get work experience in the emerging technologies of the future.
Source: BioBuzz
Read more
